Thomas Marron, MD, PhD
Director, Early Phase Trials Unit, The Tisch Cancer Institute
Professor of Medicine
Professor of Immunology and Immunotherapy
Icahn School of Medicine at Mount Sinai
Related Videos
Video
Cancer Immunotherapy at Mount Sinai: Progress Towards Curing the Uncurable
Mount Sinai is moving the bar on immunotherapy to improve outcomes for patients
Video
Cancer Immunotherapy: In Search of the Other “C” Word (Cure) for Cancer Patients
Moving Cancer Immunotherapy Forward